As the results show, the mutation in exon 7 of the TP53 gene is statistically related to the risk of metachronous adenoma, so patients harboring this mutation in index lesions likely have a higher risk of early metachronous adenoma occurrence. This evidence concerns the gene TP53 and adenoma.